MedTrace Logo

Interval Between Neoadjuvant Therapy and Surgery in the Treatment of Locally Advanced Rectal Cancer (CRONOS)

NCT04717947 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 911

Last updated 2021-02-04

No results posted yet for this study

Summary

The investigators evaluate the response of rectal cancer to neoadjuvant therapy and classify the response according to specific periods of time after the end of neoadjuvant treatment.

Conditions

Interventions

PROCEDURE

Interval between NAT and surgery

Evaluate three groups according to the interval between the end of neoadjuvant therapy and surgery.

Sponsors & Collaborators

  • Complejo Hospitalario Universitario de Santiago

    collaborator OTHER

  • Hospital Universitario Marqués de Valdecilla

    collaborator OTHER

  • Hospital de Sant Joan Despí Moisès Broggi

    collaborator OTHER

  • Hospital del Mar

    collaborator OTHER

  • Hospital Son Espases

    collaborator OTHER

  • Hospital Universitario La Fe

    collaborator OTHER

  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

    collaborator OTHER

  • Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion

    collaborator OTHER

  • Hospital Clinic of Barcelona

    lead OTHER

Principal Investigators

  • Antonio Lacy, PhD · Hospital Clinic of Barcelona

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-25
Primary Completion
2020-02-25
Completion
2021-06-25

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04717947 on ClinicalTrials.gov